--- canonical: https://trinta.ai/blog/medical-device-tenders-in-latin-america-regulation-meets language: en updated: 2026-09-08 publisher: "TRINTA" publisher_url: https://trinta.ai --- # Medical Device Tenders in Latin America: Regulation Meets Procurement > How ANVISA, COFEPRIS and INVIMA registration interacts with public tenders, distributor versus direct models, and the health procurement calendar. Source: https://trinta.ai/blog/medical-device-tenders-in-latin-america-regulation-meets · Published: 2026-09-08 · Category: Latin America · 4 min read Keywords: medical device tenders Latin America, ANVISA registration tender, COFEPRIS medical device tender, INVIMA registration Colombia, Latin America health procurement, medical device distributor Latin America Winning a medical device tender in Latin America is really two separate challenges that happen to arrive at the same time. The first is standard public procurement competence: understanding the tender, pricing correctly, meeting delivery and service requirements. The second, and the one that trips up more suppliers, is regulatory: a device generally cannot be sold into a public tender in these markets without first clearing the national health regulatory authority's registration process, a process that runs on its own timeline, entirely separate from any specific tender's deadline. Understanding how registration through bodies like ANVISA in Brazil, COFEPRIS in Mexico and INVIMA in Colombia interacts with the public procurement process, well before a specific tender appears, is what separates suppliers who can move quickly on a health tender from those who discover the regulatory gate too late to compete. ## Registration as a prerequisite, not a parallel track In each of these major Latin American markets, a medical device generally needs valid registration with the national health regulatory authority before it can be legally sold, including into public sector contracts. This means regulatory registration functions less like a competing workstream running alongside tender preparation and more like a hard prerequisite: a company without current registration for a given device is often simply ineligible to bid, regardless of how strong its price or technical proposal would otherwise be. The practical implication is that registration timing needs to be planned around a company's market entry strategy generally, not around any single tender's publication date, since the registration process itself typically takes considerably longer than a standard tender's submission window allows for if started from scratch after a notice appears. ## ANVISA in Brazil ANVISA, Brazil's national health surveillance agency, oversees medical device registration for the Brazilian market, classifying devices by risk category with correspondingly different registration pathways and requirements. Brazil represents one of the largest health procurement markets in the region, spanning federal, state and municipal health systems, so navigating ANVISA registration properly is foundational for any supplier serious about the Brazilian public health market specifically, separate from the tender bidding process itself. ## COFEPRIS in Mexico COFEPRIS, the Federal Commission for the Protection against Sanitary Risk, performs the equivalent function in Mexico, regulating medical device registration and market authorisation. Mexican public health procurement runs through both federal institutions and state level health systems, and as in Brazil, valid COFEPRIS registration is generally a precondition for participating in public health tenders rather than something that can be sorted out reactively once a specific opportunity appears. ## INVIMA in Colombia INVIMA, Colombia's National Institute for Food and Drug Surveillance, handles medical device registration in the Colombian market. Colombia's health system, which blends public and private elements in a structure distinct from some of its neighbours, still requires INVIMA registration as a foundation for public sector sales, and suppliers entering the Colombian market should treat this registration process with the same seriousness and lead time planning as in Brazil and Mexico. ## Distributor versus direct models Foreign medical device manufacturers entering these markets generally choose between establishing a direct local registration and sales presence, or working through an established local distributor who already holds relevant registrations or can manage the registration process on the manufacturer's behalf. The distributor model tends to lower the barrier to entry and reduce the manufacturer's direct regulatory burden, but it also means ceding some control over pricing, tender relationships and margin to the distribution partner. A direct model offers more control and typically better margin over time, but requires a genuine, sustained local investment in regulatory and market presence that not every manufacturer, particularly smaller ones testing a new market, is ready to commit to upfront. Many suppliers start with a distributor relationship and transition toward more direct involvement as volume in a given market justifies the investment. ## The health procurement calendar Public health procurement in these markets, as elsewhere, tends to follow budget cycles tied to each country's fiscal year, with a corresponding concentration of tender activity in the months following budget approval. Understanding each country's specific fiscal calendar, and the typical timing of major health tender waves within it, helps suppliers plan registration completion and bid resourcing well ahead of the period when the bulk of the year's opportunity actually appears. ## Monitoring Latin American medical device tenders without the manual work Between three distinct regulatory authorities, federal and state level health systems in each country, and fiscal calendars that do not align across markets, tracking medical device opportunity across Brazil, Mexico and Colombia manually is a significant undertaking. TRINTA reads what a company sells and surfaces matched tenders from official sources across these markets daily, so a supplier with the right registrations in place sees the relevant health tenders as they are published, without monitoring three separate national systems by hand. ## Frequently asked questions **Do medical devices need regulatory registration before bidding on Latin American public tenders?** Generally yes. In Brazil, Mexico and Colombia, a medical device typically needs valid registration with the national health regulatory authority, ANVISA, COFEPRIS or INVIMA respectively, before it can be legally sold, including into public tenders. Registration is usually a hard prerequisite rather than something that can be completed after a tender is won. **What is ANVISA and why does it matter for medical device suppliers?** ANVISA is Brazil's national health surveillance agency, responsible for classifying and registering medical devices by risk category before they can be sold in Brazil. Since Brazil's public health procurement spans federal, state and municipal systems, valid ANVISA registration is foundational for any supplier targeting the Brazilian public health market. **What is the difference between COFEPRIS and INVIMA?** COFEPRIS is Mexico's regulatory body for medical device registration and market authorisation, while INVIMA performs the equivalent function in Colombia. Both require valid registration as a precondition for participating in public health tenders in their respective countries, similar to ANVISA's role in Brazil. **Should a foreign medical device company use a distributor in Latin America?** It depends on the company's resources and market ambitions. A distributor who already holds relevant registrations lowers the barrier to entry and reduces regulatory burden, while a direct model offers more control over pricing and tender relationships but requires sustained local investment. Many manufacturers start with a distributor and move toward direct involvement as volume grows. **How long does medical device registration take in these markets?** Registration timelines vary by device risk classification and country, but the process typically takes considerably longer than a standard tender's submission window. Suppliers should plan registration around their general market entry strategy rather than waiting until a specific tender is published. --- All guides: https://trinta.ai/blog · Site index for agents: https://trinta.ai/llms.txt